Qin Weiwei, Chen Liang, Wang Zhiru, Li Qian, Fan Chunhai, Wu Minhao, Zhang Yuanqing
Guangdong Key Laboratory of Chiral Molecule and Drug Discovery School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou Guangdong 510006 China.
College of Materials and Energy South China Agricultural University Guangzhou Guangdong 510642 China.
Adv Sci (Weinh). 2020 Aug 9;7(19):2000647. doi: 10.1002/advs.202000647. eCollection 2020 Oct.
The capture and analysis of circulating tumor cells (CTCs) have provided a non-invasive entry for cancer diagnosis and disease monitoring. Despite recent development in affinity-based CTCs isolation, it remains challenging to achieve efficient capture toward CTCs with dynamic surface expression. Enlightened by the synergistic effect insideimmune synapses, the development of a nanointerface engineered with topology-defined anisotropic aptamers programmed by DNA scaffold (DNA nanosynapse), for accurate CTCs isolation, is herein reported. As compared to isotropic aptamers, the DNA nanosynapse exhibits enhanced anchoring on the cell membrane with both high and low epithelial cell adhesion molecule (EpCAM) expression. This nanointerface enables accurate capture toward CTCs of heterogeneous EpCAM, without dramatically proportional change inside the mixture of diverse phenotypes. By applying this nanoplatform, CTCs detection as well as downstream analysis for measuring disease status can be achieved in clinical samples from breast cancer patients.
循环肿瘤细胞(CTC)的捕获和分析为癌症诊断和疾病监测提供了一种非侵入性途径。尽管基于亲和力的CTC分离技术最近有所发展,但对于动态表面表达的CTC实现高效捕获仍然具有挑战性。受免疫突触内协同效应的启发,本文报道了一种由DNA支架编程的具有拓扑定义的各向异性适体工程化的纳米界面(DNA纳米突触),用于精确分离CTC。与各向同性适体相比,DNA纳米突触在高表达和低表达上皮细胞粘附分子(EpCAM)的细胞膜上均表现出增强的锚定作用。这种纳米界面能够精确捕获异质性EpCAM的CTC,而不会在不同表型的混合物中发生显著的比例变化。通过应用这种纳米平台,可以在乳腺癌患者的临床样本中实现CTC检测以及用于测量疾病状态的下游分析。